Skip to content

Budesonide Impurity 4

Budesonide Impurity 4

Product Description
CAT No.
ALN-B022035
CAS No.
77017-17-5
Mol. F.
C21H26O5
Mol. Wt.
358.4
Stock
Please Inquire
Chemical Name : (6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7,10-Dihydroxy-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2′,1′:4,5]indeno[2,1-b]furan-4,9(10H)-dione
Smiles : C[C@]1(C=C2)C(CC[C@]3([H])[C@]1([H])[C@](O)([H])C[C@@]4(C)[C@@]3([H])C[C@@]([H])(OC(O)C5=O)[C@]45[H])=CC2=O
Inchi : InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m1/s1/i1D3

A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers

By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, NagarajnFrom Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852

Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC

By Raghu, P. S. – From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6

Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy

By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha – From American Journal of Analytical Chemistry (2017), 8(7), 449-461

Request For Quotation